Capsule is a healthcare technology business rebuilding the pharmacy from the inside out.
Capsule delivers prescription drugs to local patients in two hours via an online app, said it is in the process of applying for pharmacy licenses in additional states.
Capsule was founded in 2016 by Eric Kinariwala and is based in New York, New York.
Capsule’s app allows patients to schedule delivery within a two-hour period, and gives users information on their co-payment and possible drug side effects. It also allows them to ask a pharmacist questions via secure chat or text.
Capsule is rebuilding the $425 billion pharmacy industry from the inside out with an emotionally resonant brand and technology that enables customized outcomes for doctors, hospitals, insurers, and manufacturers.
Capsule's software also has features to make prescribing easier for doctors, allowing them to set up refill preferences and specify alternate drugs if a patient’s insurance won’t cover the first choice. The company has 60,000 customers in New York, most on multiple medications.
Capsule is backed by investors including TCV, Thrive Capital, Glade Brook Capital Partners, & The Virgin Group among others. The company raised a whopping $200M in its latest "Series C" financing on Sep 13, 2019. This brings Capule's total funding to $270M to-date.